824 related articles for article (PubMed ID: 18181719)
1. The US Food and Drug Administration and probiotics: regulatory categorization.
Degnan FH
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
[TBL] [Abstract][Full Text] [Related]
2. Health-benefit claims for probiotic products.
Heimbach JT
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
[TBL] [Abstract][Full Text] [Related]
3. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
Saldanha LG
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
[TBL] [Abstract][Full Text] [Related]
4. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
Frankos VH; Street DA; O'Neill RK
Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
[TBL] [Abstract][Full Text] [Related]
5. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
Roller ST; Pippins RR; Ngai JW
Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
[TBL] [Abstract][Full Text] [Related]
6. Regulation of probiotic substances as ingredients in foods: premarket approval or "generally recognized as safe" notification.
Mattia A; Merker R
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S115-8; discussion S144-51. PubMed ID: 18181714
[TBL] [Abstract][Full Text] [Related]
7. Probiotic foods and drugs: impact of US regulatory status on design of clinical trials.
Hibberd PL; Davidson L
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S137-40; discussion S144-51. PubMed ID: 18181720
[TBL] [Abstract][Full Text] [Related]
8. Development of probiotics as biologic drugs.
Hoffman FA
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S125-7; discussion S144-51. PubMed ID: 18181717
[TBL] [Abstract][Full Text] [Related]
9. Business considerations in the development of probiotics.
Hoffman FA
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S141-3; discussion S144-51. PubMed ID: 18181721
[TBL] [Abstract][Full Text] [Related]
10. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
[TBL] [Abstract][Full Text] [Related]
11. Iron-containing supplements and drugs; label warning statements and unit-dose packaging requirements; removal of regulations for unit-dose packaging requirements for dietary supplements and drugs. Final rule; removal of regulatory provisions in response to court order.
Food and Drug Administration, HHS
Fed Regist; 2003 Oct; 68(201):59714-5. PubMed ID: 14567392
[TBL] [Abstract][Full Text] [Related]
12. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.
Saxelin M
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S76-9; discussion S144-51. PubMed ID: 18181728
[TBL] [Abstract][Full Text] [Related]
13. Current marketplace for probiotics: a Japanese perspective.
Amagase H
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S73-5; discussion S144-51. PubMed ID: 18181727
[TBL] [Abstract][Full Text] [Related]
14. Functional foods: the Food and Drug Administration perspective.
Ross S
Am J Clin Nutr; 2000 Jun; 71(6 Suppl):1735S-8S; discussion 1739S-42S. PubMed ID: 10837331
[TBL] [Abstract][Full Text] [Related]
15. Medical devices: the obvious, the readily-accepted, and the surprising.
Tolomeo DE; Clarke LA
J Health Life Sci Law; 2008 Jul; 1(4):117, 119-44. PubMed ID: 18717154
[TBL] [Abstract][Full Text] [Related]
16. Ephedra: yesterday, DSHEA, and tomorrow--a ten year perspective on the Dietary Supplement Health and Education Act of 1994.
Seamon MJ; Clauson KA
J Herb Pharmacother; 2005; 5(3):67-86. PubMed ID: 16520299
[TBL] [Abstract][Full Text] [Related]
17. Clinical research on probiotics: the interface between science and regulation.
Tamayo C
Clin Infect Dis; 2008 Feb; 46 Suppl 2():S101-3; discussion S144-51. PubMed ID: 18181711
[TBL] [Abstract][Full Text] [Related]
18. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
19. Is my yogurt lying? Developing and applying a framework for determining whether wellness claims on probiotic yogurts mislead.
Satine LA
Food Drug Law J; 2008; 63(2):537-77. PubMed ID: 18561477
[No Abstract] [Full Text] [Related]
20. [State surveillance and control of food quality and safety in USA].
Berman VA
Vopr Pitan; 2003; 72(2):22-7. PubMed ID: 12924205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
